Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
AqueSys, Inc. currently manages 2 pending office actions within its patent portfolio. These matters are distributed across 2 distinct examiners, indicating a specific ratio of actions to examiners at this stage of prosecution.
The busiest examiner for the portfolio is WIEST, PHILIP R, who is responsible for 1 pending office action. This specific examiner handles a portion of the company's total pending workload, while the remaining action is assigned to the other distinct examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WIEST, PHILIP R | 1 | 81.3% | +16.3% |
| WENG, KAI H | 1 | 70.2% | +17.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18894589 | INTRAOCULAR DRUG DELIVERY | WIEST, PHILIP R | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18894589 | INTRAOCULAR DRUG DELIVERY | WIEST, PHILIP R | — |
| 18807036 | INTRAOCULAR SHUNT IMPLANTATION METHODS AND DEVICES | WENG, KAI H | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18894589 | INTRAOCULAR DRUG DELIVERY | WIEST, PHILIP R | — | DP | Final Rejection | — | Pending | Sep 24, 2024 |
| 18807036 | INTRAOCULAR SHUNT IMPLANTATION METHODS AND DEVICES | WENG, KAI H | — | DP | Non-Final OA | — | Pending | Aug 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial